Nutex Health, Inc. (NUTX)
2025-03-31 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Total revenue | 211,789,000 | 78,794,869 | 76,082,261 | |
| Medical supplies | 3,801,000 | 3,982,598 | 3,588,464 | |
| Contract services | 38,655,000 | 11,657,010 | 9,505,222 | |
| Other | 11,043,000 | 6,417,886 | 7,496,465 | |
| Payroll | 34,860,000 | 29,848,083 | 28,398,075 | |
| Depreciation and amortization | 5,092,000 | 4,972,478 | 4,532,804 | |
| Total operating costs and expenses | 93,451,000 | 56,878,055 | 53,521,030 | |
| Gross profit | 118,338,000 | 21,916,814 | 22,561,231 | |
| Amount of non-cash loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized | - | - | 3,197,391 | |
| Asset impairment charges | - | 425,221 | 3,473,635 | |
| General and administrative expenses | 10,035,000 | 9,865,330 | 10,652,390 | |
| Stock-based compensation | 36,094,000 | 1,963,518 | -61,241 | |
| Total corporate and other costs | 46,129,000 | 12,254,069 | 17,262,175 | |
| Operating income (loss) | 72,209,000 | 9,662,745 | 5,299,056 | |
| Interest expense, net | 6,120,000 | 5,381,040 | 5,054,532 | |
| Other expense (income) | -3,325,000 | -128,645 | 599,502 | |
| Gain (loss) related to the warranty liability | - | -6,733,552 | 3,060,096 | |
| Income (loss) before taxes | 62,764,000 | -2,580,492 | 3,904,122 | |
| Income tax expense (benefit) | 18,541,000 | 4,584,518 | 893,892 | |
| Net income (loss) | 44,223,000 | -7,165,010 | 3,010,230 | |
| Less net income (loss) attributable to noncontrolling interests | 29,589,000 | 1,623,303 | 3,374,278 | |
| Net income (loss) attributable to nutex health inc | 14,634,000 | -8,788,313 | -364,048 | |
| Basic eps | 2.65 | -1.72 | -0.07 | |
| Diluted eps | 2.56 | -1.72 | -0.07 | |
| Basic average shares | 5,516,999 | 5,100,030 | 4,969,726 | |
| Diluted average shares | 5,853,336 | - | - | |